Relationship between lipoprotein(a) and PCSK9 in angiogram-proven premature coronary artery disease in an Asian cohort
Authors:
Open Access
- 22 January 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Coronary artery disease (CAD) has been associated with elevated Lp(a) levels, yet the mechanism driving the pro-atherogenic and inflammatory effects remains unclear. Proprotein convertase subtilisin/kexin type 9 (PCSK9), a key regulator of lipid metabolism with emerging roles in vascular inflammation. This study explored the relationship between Lp (a) and PCSK9 in an Asian cohort with angiogram-proven premature CAD (AP-pCAD), with and without familial hypercholesterolemia (FH). Patients were recruited from Cardiology and Specialist Lipid Clinics; grouped into pCAD with FH ( n = 70), pCAD without FH ( n = 65), and normal controls (G3; n = 69). FH was clinically diagnosed using the Dutch Lipid Clinic Network. Lp(a) and PCSK9 levels were measured using an automated chemistry analyser and ELISA. Lp(a) and PCSK9 levels were significantly higher in pCAD groups compared to controls. No significant correlation between Lp(a) and PCSK9 was observed in individual pCAD subgroups (G1 or G2); a weak positive correlation was found in the normal control group (G3; r = 0.366, p = 0.019). In multivariate analysis, Lp(a) emerged as a significant independent predictor of pCAD (adjusted OR: 5.036, p = 0.015). In conclusion, Lp(a) independently predicts pCAD, while its association with PCSK9 appears modest and context-dependent, suggesting a more complex interplay possibly influenced by lipid-lowering therapy such as statin use.Keywords
This publication has 86 references indexed in Scilit:
- Lipoprotein(a) and its Significance in Cardiovascular DiseaseJAMA Cardiology, 2022
- Prediction of cardiovascular risk by Lp(a) concentrations or genetic variants within the LPA gene regionClinical Research in Cardiology Supplements, 2019
- A Meta-Analysis of the Effect of PCSK9-Monoclonal Antibodies on Circulating Lipoprotein (a) LevelsAmerican Journal of Cardiovascular Drugs, 2018
- Lipoprotein(a) level associates with coronary artery disease rather than carotid lesions in patients with familial hypercholesterolemiaJournal of Clinical Laboratory Analysis, 2018
- Dutch Lipid Clinic Network low-density lipoprotein cholesterol criteria are associated with long-term mortality in the general populationArchives of Cardiovascular Diseases, 2015
- A Computed Tomography-Based Coronary Lesion Score to Predict Acute Coronary Syndrome Among Patients With Acute Chest Pain and Significant Coronary Stenosis on Coronary Computed Tomographic AngiogramThe American Journal of Cardiology, 2012
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial InfarctionJAMA, 2009
- Influence of race and sex on lipoprotein-associated phospholipase A2 levels: Observations from the Dallas Heart StudyAtherosclerosis, 2008
- The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African populationAtherosclerosis, 2007
- The proprotein convertases are potential targets in the treatment of dyslipidemiaJournal of Molecular Medicine, 2007